buy on the rumor sell on the news.There are many newer and better drugs coming out. Vertex will be old news soon. You can't even get anymore new and improved information about triple therapy with incivek everything coming out now is about newer drugs and shorter treatment time. I still want to know what's up with my therapy but doesn't look like we are going to hear much more. Now it's time to advertise get people tested and on their drug because they only have so much time to make their sales before the competition takes over.
I was wondering why my vertex stock dropped $20 a share in the last month or so. Even on days the market is up it still loses money. I thought once it got approved their stock would go way up. Now they show their first profit and stock is still heading down. Can't figure it out
Maybe they had to pay big bucks to insiders at the FDA :)
I just finished 12 weeks of incivek and after the 4th week i was showing negative for hep c. i am on my 12th week and just finished the incivek. i still am showing negative for hep c. i am happy but also scared since this is a new drug. has anyone else been on this drug yet and have good, long lasting results?
The training began about 2 months ago and mt Dr and RN have been to 4 weekend symposiums since.
The fadt tracking and push to get to mkt dud nit allow for time to train. Originally these tx weren't expected to be appvd till Sept 2011, then moved up by FDA.
When I state SVR's and clinicals I meant in real time presscriptions written after FDA apprvl and to market. There are still no "real" numbers post clinicals as yet. Firsts will be June 2012.
I do apologize for the error and/confussion or any offense taken by our many CLinicals who fought for us and did the tx for us to have these drugs.
Off to call the broker.....McVertex...super size mine!!!
Ahh, so that rumor IS true. Just a matter of time until we see the MCD "Hepper special" :o)
PS: I have a patch on my Geico motorcycle jacket that says "30%er"
:*) Pro
Isobella, tip of the day--buy MCD, the McRib is back.
ahhh, McRib(29 grams of fat) and a Incevik back chaser.
.rumor has it, VRTX and MCD are striking a deal.
I'm with you on this.....hopefully our SVR "patents" don't expire soon, because I'm quite sure the ones for Vic or Inc won't anytime soon.
Now a patent expiration for all the Wall Street woes....that's another story, lol!!!
" I worked at NYSE for close to 9 yrs" does that mean you failed to beat the S&P index 70% of the time as studies have shown..or are you in the 30% category?
There are no real SVR's in post clinicals yet.
Not exactly true, if I understand your meaning. I am SVR after finishing a trial with INC over 2 yrs ago. I'm sure there are many more like me. Or maybe I didn't understand you?
I'm happy these meds are finally here also. For a long time it semed like 'a long wait for a train that don' come' - just wish we knew more about which patients would benefit from them most. I hate to see people suffering unnecessarily. In a couple years it will probably be moot anyway. The obscene 'patent' on the HepC virus is set to expire soon and I suspect we'll be awash in new drugs. The fact that a handful of pills for a 12 week course of tx costs 10s of thousands of dollars leads me to suspect that there are others who see this about to happen also.
Excellent point. I guess" thinking doctors "is not something drug companies are readily promoting when prescribing these drugs Hence the beautiful young reps taking docs to expensive lunches and dinners and offers of free trips to prescribe "their drug"'
Yes profit is always first and foremost....I guess my comment was more to do with the mechanics of treatment now with these very powerful meds ( ie training better on futility rules, how and when to properly prescribed rescues, vs. dose red. or trans.,exact times to test for Vl., etc,etc) Just here on the forum we unfortunately have seen wild fluctuations by doctors on all these ,so we can only imagine what is going on widespread.
However ,I guess proper extensive training of all treating doctors would cost the drugs companies considerably and hence less profit... :)
It is great these meds have finally arrived and even better still what is more than likely to come in the future for HCV.. I would just like to have seen better ,more detailed and explicit instruction given to those trusted to administer them. as are oncologists overseeing chemo for cancer patients....
JMO
,
Yeah, but if you get doctors to thinking, they might start thinking "Which patients could still treat with SOC and respond without the added sx and which paients aren't going to respond even with a PI added on?" You start them to thinking like that, and there goes your new "SOC" along with 75% of your profits. Wouldn't want your product to only be Rxd to the 25% who actually need it to sustain a response.
There are still sooooo very many Drs who know NOTHING about these drugs and are putting horrible info out to our fellow heppers who could be tx.
-------------------------------------------------------------------------------------------------------
Well said....." I have always maintained "Pharma may have put the drugs in clinical practice somewhat hastily before proper explicit training was given to many treating doctors. Possibly some of their new found profit should be invested in hiring reps to train ,,rather than be so quick to sell..
Will....
There are no real SVR's in post clinicals yet. We have to wait out another 9 months to see the real deal when the true bloods come rolling in. Only then will the truth be put to paper. I worked at NYSE for close to 9 yrs and have seen this happen b4. If i had some cash I'd buy what I could. I'd even buy Merck, the VA just signed a contract w them for Victrelis for the Vets. Yeah it'll be great to see all these SVR's.
Late August, the # of patients on INC including clincals was at 8k so I wonder if 17k includes those in the waiting queue, like I was; for two months b4 tx began. Sometimes it's nice to fluff the pillows so to speak. There are still sooooo very many Drs who know NOTHING about these drugs and are putting horrible info out to our fellow heppers who could be tx. Pray for us all, continue to fight the good fight. Kbow that we are like the clincal folks, pioneers in a new drug and brave enough to check it out unforseen so to speak, all in the name of Life. Healing happy vibes :)
Incevik is Telepravir. It was called Teleprevir when it was a trial drug.
I haven't been on the forum in a while. What is Incivek ? I thought Vertex was making Telapriver !
so why is their stock tanking? Hi at FDA approval was $54, never to reach that again. Now has slipped in the $30s
When one considers that 17K number includes backlog/pent up demand from those waiting on the new tx, the numbers were not as impressive as the analysts would lead you to believe. I believe the stock will be trading in the 30's in short order (yes, pun intended)
The blew the doors of the Wall Street estimates and are on track to have the fastest rise to profitability of any biotech firm ever.
http://finance.yahoo.com/news/Vertex-Pharmaceuticals-wscheats-3718587781.html?x=0
I wonder how many are taking the Victrelis? I think it was approved one day before the Incivek was approved back during May.